Epilepsy: clinical trials and information
Epilepsy clinical trials in Canada
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care NCT01431326 | Completed | Manitoba, Ontario, Quebec | Daniel Benjamin | 2011-11 |
Epilepsy clinical trials worldwide (outside Canada)
11 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| The Living With a Long-Term Condition Study NCT06072287 | Unknown status | United Kingdom | King's College London | 2023-06-28 | |
| Quest to Analyze One Thousand Humans Meditating NCT06583395 | Enrolling by invitation | United States | Tobias Moeller-Bertram | 2021-12-05 | |
| Manipulating and Optimising Brain Rhythms for Enhancement of Sleep NCT05011773 | Completed | Not applicable | United Kingdom | University of Oxford | 2021-08-03 |
| Outcomes Mandate National Integration With Cannabis as Medicine NCT03944447 | Unknown status | Phase 2 | United States | OMNI Medical Services, LLC | 2018-12-01 |
| fMRI in Deep Brain Stimulation NCT03819738 | Unknown status | Not applicable | Belgium | Universitaire Ziekenhuizen KU Leuven | 2017-03-24 |
| Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use NCT02977208 | Completed | Phase 4 | Brazil | São Paulo State University | 2016-09 |
| PatientSpot Formerly Known as ArthritisPower NCT03840928 | Unknown status | United States | Global Healthy Living Foundation | 2015-04-01 | |
| Cancer in Patients With Gabapentin (GPRD) NCT01236053 | Completed | GlaxoSmithKline | 2010-06 | ||
| Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) NCT01138124 | Completed | GlaxoSmithKline | 2010-03 | ||
| Clinical Applications of High-Frequency Oscillations NCT00600717 | Withdrawn | United States | Children's Hospital Medical Center, Cincinnati | 2000-11-01 | |
| Exploring the Comorbidity Between Mental Disorders and General Medical Conditions NCT03847753 | Completed | University of Aarhus | 2000-01-01 |
About Epilepsy
What is Epilepsy?
"Epilepsy" is the term study registrants used on ClinicalTrials.gov. Registry labels are not always standard medical terms, and close variants of the same label appear as separate entries. In this snapshot the term appears on 12 chronic pain registry records worldwide.
How is Epilepsy usually assessed?
Assessment of chronic pain generally involves a clinician taking a detailed history, a physical examination and, where relevant, tests to look for underlying causes. Pain rating scales and questionnaires about function, sleep and mood are often used. The approach depends on the person and the condition.
What kinds of treatments are studied for Epilepsy?
Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.
How can I find Epilepsy clinical trials in Canada?
This page lists 1 registry record for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.
Related interventions
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.